Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
33°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
IQ-AI advances glioblastoma clinical trial, eyes phase two in 2025
February 26, 2024
Via
TheNewswire.com
Exposures
Product Safety
Better Therapeutics Follows Up Wins Including FDA Authorization For AspyreRx In 2023 With Securing FDA Breakthrough Device Designation Targeting Advanced Liver Disease
February 26, 2024
Via
News Direct
Exposures
Product Safety
Tickers
BTTX
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
BEAM
BLBD
BLUE
CRSP
ROSEN, A LEADING NATIONAL FIRM, Encourages InMode Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INMD
February 25, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants
February 20, 2024
Via
News Direct
Exposures
Product Safety
ROSEN, A LEADING NATIONAL FIRM, Encourages InMode Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INMD
February 25, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
February 24, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
February 24, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
Kerassentials 2024 Review: Truth About The Product (Read Before Buying)
February 23, 2024
Via
AB Newswire
Exposures
Product Safety
How Medicare Advantage addresses the social drivers of health
February 23, 2024
Via
Brandpoint
Topics
Product Recall
Exposures
Legal
Product Safety
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages InMode Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INMD
February 23, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages InMode Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INMD
February 23, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
Cancer Test Focused Guardant Health Stock Falls On FDA AdCom Update For Colorectal Test
February 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
GH
Do Not Use Smartwatches, Rings That Claim To Measure Blood Sugar Without Needles, FDA Says
February 22, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AAPL
Nvidia Beats & Raises In Q4; Late Trading +8%
February 21, 2024
Via
Talk Markets
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
AMD
ETSY
NVDA
RIVN
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
February 21, 2024
Via
Benzinga
Exposures
COVID-19
Product Safety
Tickers
GSK
MRNA
PFE
What's Going On With RAPT Therapeutics Stock On Wednesday?
February 21, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
RAPT
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
February 21, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LQDA
UTHR
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at 2024 BIO CEO & Investor Conference
February 21, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
FDA Approves Johnson & Johnson's Reduced Tecvayli Dosing In Pretreated Multiple Myeloma Patients
February 21, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
JNJ
FDA Grants Florida Permission to Import More Affordable Medicines from Canada
February 21, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
SHMN
FDA Gathers Public Social Media Data To Better Understand Cannabis Users As Part Of Its Effort Toward Rescheduling Marijuana
February 20, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
ROSEN, A RESPECTED AND LEADING FIRM, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
February 20, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, A RESPECTED AND LEADING FIRM, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
February 20, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
Healthcare Innovations and Collaborations Fuel Industry Expansion Stocks Under $1 Look Now! OCGN, VTAK, RSCI, VERU, AGEN
February 20, 2024
Via
AB Newswire
Exposures
Product Safety
Tickers
OCGN
RSCI
VERU
VTAK
ARS Pharma Readies Data In Response To FDA's Rejection For Its EpiPen Alternative For Severe Allergic Reactions
February 20, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
SPRY
Why Is Iovance Therapeutics (IOVA) Stock Up 35% Today?
February 20, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
IOVA
Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeutics Shares Tumbling Today?
February 20, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
RAPT
Rapt Therapeutics Crashes 65% After Unexpected Liver Failure Sidelines Two Tests
February 20, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
RAPT
REGN
SNY
Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants
February 20, 2024
Via
TheNewswire.com
Exposures
Product Safety
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.